Where do Palvella Therapeutics's ratios come from?

Every ratio is computed from Palvella Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-92.1%—	——	——	——
Return on assets	-56.5%-20.0pp	-36.4%-72.7pp	36.3%+63.0pp	-26.7%+8.7pp
Liquidity
Current ratio	5.2×-2.1×	7.3×+4.1×	3.2×+1.2×	2×-0.5×
Quick ratio	5.2×-2.1×	7.3×+4.1×	3.2×+1.2×	2×-0.5×
Cash ratio	5.1×-1.8×	6.9×+3.8×	3.1×+2.1×	1.1×-1.3×
Leverage
Debt-to-equity	0×—	——	——	——
Debt-to-assets	0×—	——	——	0.1×0.0×
Per Share
Book value per share	$2.49-91.2%	$28.13—	——	——
Valuation
Market capitalization	$1.24B+820%	$134.66M—	——	——
Enterprise value	$1.18B—	——	——	——
Price / book	44.3×+42.1×	2.2×—	——	——
Earnings yield	-3.4%+9.6pp	-12.9%—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Palvella Therapeutics's ratios come from?: Every ratio is computed from Palvella Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.